Tyrosine Kinase Inhibitor Clinical Trials

18 clinical trials for Tyrosine Kinase Inhibitor across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia — RECRUITING
• The TASTY-training Study — RECRUITING · NA
• Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases — RECRUITING · PHASE4
• Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) — RECRUITING
• Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation — COMPLETED · PHASE2
• Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation — COMPLETED
• The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma — COMPLETED · PHASE1
• Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment — NOT_YET_RECRUITING · PHASE2
• Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL — NOT_YET_RECRUITING · PHASE2
• HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC — ACTIVE_NOT_RECRUITING
• SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma — NOT_YET_RECRUITING · PHASE2
• Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors. — COMPLETED
• Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia — OTHER
• HRQOL in Locally Advanced Thyroid Carcinoma — OTHER
• Oncotool for Cancer Medications — COMPLETED · NA
• Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants — OTHER · PHASE2

Refine this search